Financial Guidance and Outlook: Full-year 2026 revenue for IBSRELA is expected to be between $410 and $430 million, representing growth of at least 50% compared to 2025. 2029 IBSRELA revenue is expected to be $1 billion with continued growth through loss of exclusivity. Full-year 2026 XPHOZAH revenue is expected to be between $110 and $120 million.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ARDX: